Related Experiment Videos
[Molecular dialogue between human retroviruses and host cells]
1Laboratoire Infections Rétrovirales et Signalisation Cellulaire CRBM-CNRS UPR1086, Faculté de Médecine, Montpellier. devaux@crbm.cnrs-mop.fr
Journal De La Societe De Biologie
|October 30, 1999
Summary
Human retroviruses hijack host cells for replication, exploiting cell surface receptors like CD4 and CXCR4. HIV-1 envelope proteins manipulate these interactions to control cell fate, impacting disease progression.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Exogenous retroviruses cause severe human diseases.
- Retrovirus replication involves complex host-cell interactions and signal transduction pathway subversion.
- Understanding virus-host molecular crosstalk is crucial for deciphering retroviral physiopathology.
Purpose of the Study:
- To investigate the molecular mechanisms by which retroviruses interact with host cells.
- To elucidate how cell surface receptor binding by retroviruses modulates host cell homeostasis.
- To provide insight into the role of HIV-1 envelope glycoproteins in modulating host cell responses.
Main Methods:
- Review of recent data on retroviral cell surface receptor utilization.
- Analysis of molecular cross-talk between retroviruses and host cells.
- Focus on the function of HIV-1 envelope glycoproteins binding to CD4 and CXCR4.
Main Results:
- Retroviruses use diverse cell surface receptors to initiate infection.
- HIV-1 envelope glycoproteins modulate kinase activation and transcription factor nuclear translocation.
- Binding to CD4 promotes cell activation and proliferation, aiding virus production.
- Binding to CXCR4 induces apoptosis, diminishing the host immune response.
Conclusions:
- Retroviruses strategically exploit host cell surface receptors to manipulate cellular processes.
- HIV-1 envelope glycoproteins play a critical role in viral pathogenesis by altering host cell signaling and survival.
- Targeting these virus-receptor interactions could offer therapeutic strategies against retroviral infections.